Free: Mukd-546

The film features scenes where partners rotate, often involving multiple participants in a single room.

Docking studies revealed a nanomolar‑range binding energy (ΔG = –11.2 kcal·mol⁻¹) within the ATP‑binding pocket of MEK1. In vitro kinase assays confirmed a mean IC₅₀ of 8 nM against MEK1/2, with >200‑fold selectivity over a panel of 30 off‑target kinases. Mukd‑546 reduced viability of KRAS‑mutant PDAC (MIA‑PaCa‑2, IC₅₀ = 45 nM) and BRAF‑mutant melanoma (A375, IC₅₀ = 28 nM) cells, induced G₁ arrest, and triggered caspase‑3/7‑mediated apoptosis. In rats, oral administration (10 mg·kg⁻¹) yielded a bioavailability of 62 % and a half‑life of 6.3 h. In xenograft models, daily oral dosing (30 mg·kg⁻¹) for 21 days produced tumor growth inhibition (TGI) of 84 % in PDAC and 78 % in melanoma, with no significant weight loss or histopathological toxicity. mukd-546

Western blots revealed dose‑dependent reduction of p‑MEK (Ser217/221) and p‑ERK (Thr202/Tyr204) (≥ 80 % inhibition at 100 nM), alongside increased cleaved caspase‑3. The film features scenes where partners rotate, often

MUKD-546 was officially released on June 13, 2025, with expanded availability on major platforms and DVD retailers starting June 17, 2025. The production is notable for its substantial runtime, lasting approximately (3 hours and 30 minutes), which is typical for "orgy" themed releases that aim to provide an immersive experience. Plot and Theme Plot and Theme